Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| retinal pigment epithelial cell | 4 studies | 34% ± 16% | |
| astrocyte | 3 studies | 26% ± 8% |
Insufficient scRNA-seq data for expression of BCO1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 99% | 143.29 | 958 / 966 | 90% | 4.13 | 473 / 527 |
| kidney | 100% | 138.18 | 89 / 89 | 89% | 10.15 | 800 / 901 |
| brain | 91% | 48.56 | 2404 / 2642 | 85% | 3.19 | 602 / 705 |
| stomach | 90% | 36.72 | 322 / 359 | 85% | 4.57 | 242 / 286 |
| esophagus | 78% | 23.48 | 1131 / 1445 | 59% | 3.03 | 108 / 183 |
| bladder | 86% | 24.48 | 18 / 21 | 48% | 1.78 | 242 / 504 |
| uterus | 86% | 34.48 | 147 / 170 | 42% | 2.13 | 195 / 459 |
| prostate | 99% | 64.93 | 242 / 245 | 29% | 0.56 | 148 / 502 |
| ovary | 99% | 87.98 | 178 / 180 | 27% | 0.91 | 116 / 430 |
| pancreas | 38% | 5.51 | 124 / 328 | 82% | 3.47 | 146 / 178 |
| liver | 96% | 49.88 | 216 / 226 | 22% | 0.64 | 89 / 406 |
| lung | 51% | 8.73 | 295 / 578 | 44% | 1.97 | 504 / 1155 |
| skin | 67% | 20.20 | 1215 / 1809 | 3% | 0.06 | 12 / 472 |
| breast | 57% | 11.66 | 263 / 459 | 9% | 0.21 | 101 / 1118 |
| thymus | 60% | 12.38 | 394 / 653 | 6% | 0.12 | 34 / 605 |
| tonsil | 0% | 0 | 0 / 0 | 38% | 0.87 | 17 / 45 |
| adipose | 35% | 5.61 | 419 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 28% | 5.56 | 228 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 17% | 21.51 | 155 / 929 | 0% | 0 | 0 / 0 |
| heart | 12% | 1.38 | 101 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 5% | 0.53 | 12 / 258 | 2% | 0.05 | 5 / 230 |
| blood vessel | 7% | 0.82 | 88 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.20 | 3 / 80 |
| spleen | 2% | 0.17 | 4 / 241 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0035238 | Biological process | vitamin A biosynthetic process |
| GO_0001523 | Biological process | retinoid metabolic process |
| GO_0042574 | Biological process | retinal metabolic process |
| GO_1901810 | Biological process | beta-carotene metabolic process |
| GO_0042572 | Biological process | retinol metabolic process |
| GO_0016121 | Biological process | carotene catabolic process |
| GO_0005829 | Cellular component | cytosol |
| GO_0003834 | Molecular function | beta-carotene 15,15'-dioxygenase activity |
| GO_0010436 | Molecular function | carotenoid dioxygenase activity |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | BCO1 |
| Protein name | Beta-carotene oxygenase 1 Beta,beta-carotene 15,15'-dioxygenase (EC 1.13.11.63) (Beta-carotene dioxygenase 1) (Beta-carotene oxygenase 1) |
| Synonyms | BCDO BCDO1 BCMO1 |
| Description | FUNCTION: Symmetrically cleaves beta-carotene into two molecules of retinal using a dioxygenase mechanism. . |
| Accessions | H3BPA2 Q9HAY6 ENST00000563804.5 ENST00000564552.1 H3BV18 ENST00000258168.7 |